Synthesis of anti-depressant molecules via metal-catalyzed reactions: a review

Depression is one of the most mutilating conditions in the world today. It has been difficult to make advancements toward better, more effective therapies since the introduction of antidepressant medicines in the late 1950s. One important field of medicinal chemistry is the synthesis of antidepressant molecules through metal-catalyzed procedures. The important role that different transition metals, including iron, nickel, ruthenium, and others, serve as catalysts in the synthesis of antidepressants is examined in this review. Key structural motifs included in antidepressant drugs such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and others can be synthesized in a variety of effective ways using metal-catalyzed steps. This review examines current developments in the catalytic synthesis of antidepressants and their potential application over the previous thirteen years.


Ruthenium-catalyzed reactions
Selegiline when employed with L-DOPA is a highly successful treatment for both Parkinson's along Alzheimer's disease.It is a monoamine oxidase-B (MOB) antagonist that is specic and irreversible. 41,42Independent of MAO inhibitors, the propargylamine pharmacophore of selegiline and analogous drugs also seems to possess neuroprotective effects. 43e et al. undertook the synthesis of selegiline using Ru photocatalyst & chiral N,N 0 -dioxide coordinated unique earth ion L 1 which work synergistically to initiate the photocatalytic enantio-selective reductive coupling of aromatic aldehydes with nitrones.The asymmetric radical formation is sparked by chiral Lewis acid, which serves as a crucial framework for assembling the essential precursor and produces enantiopure vicinal hydroxyl amino alcohols in good to outstanding yields exhibiting great stereo-selectivity.Here, Sc(OTf) 3 serves as the Lewis acid & Ru(bpy) 3 (PF6) 2 (photocatalyst).Asymmetric reductive coupling of benzaldehyde with nitrone 1 gave the product 2 as the key diastereomer 11/1 dr with 94% enantiomeric excess (ee).Additionally, ®-methamphetamine hydrochloride 3 was produced by dehydroxylating vicinal hydroxyamino alcohol 2 in an aq.HCl at moderate Pd/C-catalyzed hydrogenolysis.Crude 3 was N-propargylated with K 2 CO 3 in acetonitrile to get (−)-selegiline 4 (Scheme 1).
Aer Ru(bpy) 3 2+ is photoexcited and reductively quenched by DIPEA, [iPr 2 (Et)Nc] + and Ru(bpy) 3+ (E1/2II/I = 1.33 V vs. SCE in MeCN) are generated.This is sufficiently to reduce complex A via intermolecular SET (onset potential E op > −0.5 V vs. SCE) and yield the radical complex B. Indeed, DFT calculations conrmed that the electron affinity of A is much higher (∼63.0 kcal mol −1 in free energy) than that of nitrone 1 (∼23.4kcal mol −1 ) and 4-uorobenzaldehyde (∼45.1 kcal mol −1 ) in solvent, and the as-generated crosscoupling precursor B has spin density localized predominantly on the aldehyde moiety.Subsequently, N-radical intermediate C (or C 0 of anti-conguration) is formed through an analogous 6-endo-trig radical annulation, and the transition state TS B leading to a syn-conguration is predicted to be by 1.9 kcal mol −1 favored over the anti-conguration transition state TS B 0 , C upon hydrogen abstraction from [iPr 2 (Et)Nc] + affords regioselectively intermediate D (via TS C ) other than D 0 (via TS C 0 ).Finally, protonation of D gives the desired vicinal hydroxyamino alcohol 2 as a major diastereomer.Moreover, DFT calculations also showed that the formation of crosscoupling precursor B is overwhelmingly favored over the formation of homocoupling precursors, accounting well for the reaction specicity towards cross-coupling rather than homocoupling.Based on this mechanism, the diastereoselectivity of vicinal hydroxyamino alcohols, such as 2, can be analyzed by comparing the energy of the six-member ring transition state TS B with that of TS B 0 .Chiral scandium complex I, which involves a Re-to-Re-facial assault of the ketyl radical to nitrone 1, exhibits enantioselectivity (Fig. 2). 44,45n medicinal chemistry, the polyethylene glycol scaffold has gained much signicance.Rossi et al. described the hydrogen borrowing reductive amination method of PEG functionalization of amines was described.This was achieved by reacting the  phosphorus-containing dppf or DPE with the catalyst [Ru(pcymene)Cl 2 ] 2 to produce a range of 1°and 2°amine products.They were able to directly produce quetiapine 6 from 11-(piperazine-1-yl)-dibenzo[b,f] [1,4]thiazepine 5 in 62% isolated yield (Scheme 2). 46ecently, ketamine & its (S)-enantiomer, esketamine, were investigated for their immediate anti-depressant effects and have been proposed as a potential medication for depressive disorder, as well as resistant depression. 47In vitro, (S)-ketamine (esketamine) has a 3-4 fold higher affinity than (R)-ketamine for the glutamate N-methyl D-aspartate receptor. 48Esketamine has attracted more interest in the advancement of an antidepressant drug in short-term treatment. 49,50Chen & Lu synthesized Ketamine which primarily functions as a non-competitive NMDA receptor antagonist. 51,52he Noyori catalytic AH of enone 10 was used to set up the stereogenic center in 11 and the [3,3]-sigmatropic rearrangement of the allylic cyanate intermediate 14 to generate the quaternary stereogenic center in isocyanate 15 with exceptional stereochemical relay were two features of the small-scale asymmetric synthesis of esketamine.For the asymmetric reduction of enone 10, several ruthenium-based catalysts were investigated; however, at 0.1% loading, only [(S,S)-Teth-TsDPEN] RuCl afforded full conversion in 97-98% ee (Scheme 3). 53,54ther pharmaceutically useful substances, NK 1-receptor antagonist, antifungal amorone, and SCH50911 GABAantagonist, contain reboxetine, which is a SNRI. 55on & Lee developed the dynamic kinetic resolutionmediated asymmetric transfer hydrogenation (ATH) of 2benzoyl morpholine-3-ones served as a crucial step in the stereoselective synthesis of reboxetine 26.With a 93% yield, the Nbenzyl-2-aroylmorpholin-3-one 20 was produced when the Nbenzyl-3-morpholinone 18 was condensed with N-aroylmorpholines 19 in the presence of LDA.The alcohols (2R,3S)-21 and (2S,3R)-22 were produced in a combined yield of 90% by the ATH reaction of 20 with catalyst (S,S)-RuCl(TsDPEN) L 3 , which was mediated by dynamic kinetic resolution.Aer being reduced by BH 3 THF, the lactam 21 produced the corresponding morpholine benzyl alcohol 23 in 97% yield, which was then processed by Ph 3 PBr 2 to produce the respective morpholine bromide derivatives 24 in 95% yield.In the presence of t-BuOK, molecule 24 underwent bromide displacement with 2-ethoxyphenol to generate the N-benzyl-protected derivatives 25 91% of the time.Aer being treated with chloroethyl chloroformate and methanolysis, the compound 25 synthesized the target molecule (S,S)-reboxetine 26 with an 86% yield (Scheme 4). 56 SSRI antidepressant, nor-sertraline is a sertraline analog.Thalen et al. developed a new pathway to 33 using CALB, isopropyl acetate, and Na 2 CO 3 in toluene and readily available 1, 2, 3, and 4-tetrahydro-1-naphthyl amine 27 and DKR of primary amines was developed.To start, the standard procedure was used to apply DKR to achieve 28 in 70% yield and 99% ee.KMnO 4 had an impact on oxidation at the C-4 position to produce 29.Following the formation of the enolate and its trapping with N-phenyl-bis(triuoromethanesulfonimide), the resultant compound 30, reacted with 3, 4-dichlorophenyl boronic acid to generate 31 with a 96% yield and 99% ee.It was possible to obtain 32 in 95% with a trans/cis ratio of >99 : 1 using trans selectivity hydrogenation with the Crabtree catalyst.Following the deprotection of the acetamide in an acidic environment, nor-sertraline 33 produced a yield of 95% with full retention of dr and ee (99% ee, and trans/cis >99 : 1) (Scheme 5). 57räff et al. reported the lipase-catalyzation via kinetic resolution of a racemic b-hydroxy nitrile leading to the stereoinversion to produce the eutomer (S)-duloxetine through Mitsunobu yields an enantiopure R diastereomer of duloxetine. 58y using the DKR process, the yields were signicantly improved.Candida antarctica lipase as well as ruthenium catalyst (Shvo's catalyst) L 5 , were employed in the DKR of the starting molecule b-hydroxy nitrile 35 to produce the analogous b-cyano acetate 36 in yield of 87% & 98% ee.The production of both (R)-37 as well as (S)-duloxetine 38 was made possible by subsequent synthetic procedures (Scheme 6). 59

Iron-catalyzed reactions
Allen et al. reported the synthesis of moclobemide 41 using Fe (NO 3 ) 3 $9H 2 O, a low-cost catalyst, in a modest isolated yield by using readily available starting materials such as nitrile 39 and amine 40.When primary unbranched amines combine with nitriles that are not excessively electron-rich, the reaction is most favoured (Scheme 7). 60hopadea et al. reported an effective and convenient procedure for the Michael addition using Fe(acac) 3 (5 mol%) as an effective catalyst, which catalyzes the Michael addition reaction of nitromethane to chalcone to produce corresponding gnitroketone derivatives with good yields under milder conditions.
Chalcone 42 as the starting material was added to ironcatalyzed Fe (acac) 3 (5 mol%), and Michael's addition of nitromethane produced g-nitro ketone 43 in 82% of the reactions.The Baeyer-Villiger reaction 43 using H 2 O 2 in AcOH provided the analogous g-nitro ester 44.Following a Ni-catalyzed reduction of the NO 2 using sodium borohydride in combination with nickel chloride to generate cyclic amide as (±)-rolipram 45 in 3 steps with a total yield of 52.16%.(±)-Rolipram 45 acts as a neurotransmitter inhibitor drug molecule (Scheme 8). 61,62

Nickel-catalyzed reactions
Illudalic acid is "the rst potent, selective" MAOI, with an IC 50 value of 18 ± 7.1 M in initial testing.Gaston et al. reported the alkaloid network that enables the formation of illudalic acid is illudinine.The synthesis of illudinine begins with known diyne 48, produced from isophorone 46 that underwent Eschenmoser-Tanabe fragmentation, was subsequently lithiated at a terminal (h)-bonds and carboxylated to diester 49.Under MW irradiation in C 6 H 5 CH 3 for two minutes at a power of 300 W, this molecule 49 was directed with alkyne 50 via a Ni(CO) 2 (PPh 3 ) 2 -catalyzed [2 + 2 + 2] cyclo-trimerization.The alkyne 50 was chosen as the PMB group may be effectively eradicated in an oxidation step to complete the whole synthesis.The cyclotrimerization product 51 was separated in an 84% yield.The phenolic OH was effectively introduced at C-7 in the subsequent steps.Remarkably, the 3°alcohol 52 was the single product produced at 84% when 51 was treated with an excess of CH 3 Li in CeCl 3 .Treatment with BF 3 OEt 2 /H 2 O 2 in DCM at 0 °C mediates the successive carbenium ion rearrangement of 52 to 53.A 92% yield of phenol 53 is produced when the Boc group is simultaneously removed, and this prepares the way for the traditional Pictet-Spengler reaction to assemble the tricyclic skeleton.The corresponding tetrahydro iso-quinoline is produced by treating 53 with formaldehyde along with a sodium acetate buffer, and it is then immediately transformed to the methyl ether 54, treated with trimethylsilyl diazomethane (66% over two steps).Pd/C in mesitylene was used to oxidize 54 to iso-quinoline 55 at a temperature of 185 °C.In a combined yield of 58%, these conditions result in the simultaneous exclusion of the PMBprotecting group.This extremely selective and converged total synthesis of illudinine 56 is nished by quantitatively saponifying the ester by 40% aq.KOH in EtOH/H 2 O has a ratio of (95 : 5) (Scheme 9). 63erotonin reuptake and other anxiety-related illnesses are specically blocked by sertraline hydrochloride. 64Sertraline 145 has one or more asymmetric centers, and as a result, the naturally dynamic 1S,4S-enantiomer, and sertraline, must be produced with great optical purity.
Poremba et al. developed Ni-catalyzed enantio-selective reductive coupling that produces 1,1-diarylalkanes with increased yields and enantioselectivity, using 4-heptyl-BiOX L 6 .Chiral tetrahydronaphthalene 149 is produced in 70% yield and 84% ee by cross-coupling 1-chloro-1,2,3,4-tetrahydronaphthalene 57 with widely accessible iodobenzene 58.Tetralone 60 was produced in 51% yield by the benzylic oxidation of 59 utilizing CrO 3 having 3 equiv.in AcOH/H 2 O. Tetralone 60 and N-methyl hydroxylamine are condensed to form nitrone 61, whose reduction yields the required amines (sertraline) 34 (Scheme 10). 65en et al. described new lactam-fused chroman compounds with dual affinities for the 5-HT1A as well as the serotonin transporter. 66,67An effective pathway to intermediates 66 was necessary for the formation of des-uoro lactam-chroman amines 76.Under the specied conditions, the aryl halide 63 was converted to the toluene derivative 64 at the start of the reaction.Aryl bromide and alkyl zinc undergo a cross-coupling that is accelerated by a transition metal.Bis-(triphenylphosphine) nickel(II) dichloride catalyzed the reaction of 63 at 50 °C using dimethylzinc in DMF, resulting in 64.The production of the ve-membered lactam 66, which results in the regioselective isomer 74, was eventually made possible by the production of 64.Reductive amination was the strategy they had in mind for the synthesis of indoles to produce the necessary end products.The penultimate secondary amines 76 of new lactam-fused chroman compounds, primarily compound 77/78 having dual affinity at the 5-HT1A as well as the serotonin transporter in vitro cAMP turnover model, were produced by reductive amination of lactam-fused chroman amines via indole-substituted alcohols 75 (Scheme 11). 68urutachi et al. reported A hetero-bimetallic Ni/La-salan 2d complex of phosphine oxide was used in the catalytic decarboxylative 1,4-addition to 4-MeO-3-cyclopentyloxyC 6 H 3substituted nitro-alkene 79, which produced product 81 in 80% yield and 93% ee.By treating 81's nitro group with Zn and (CH 3 ) 3 SiCl, the nitro group was converted to an amine, and subsequent cyclization occurred during workup to produce (S)rolipram 34 in yield of 83% (Scheme 12). 697][78][79] The direct C(sp 2 )-H thiolation of amides and suldes was effectively used as the crucial step in the formation of quetiapine.
Li & wang reported the synthesis of quetiapine an atypical antipsychotic drug that has been licensed for treating bipolar disorder and schizophrenia. 80,81For accessing quetiapine this synthetic approach was constructed using direct C-H thiolation of benzamides as opposed to the conventional synthetic procedure, which involved cross-coupling of benzenethiols and aryl halides. 80,82,83The anticipated product 83 on a gram scale was produced by thiolating 1,2-diphenyldisulfane with 2benzamidopyridine-1-oxide 82.Then, by hydrolyzing the amide, a derivative of benzoic acid 84 was produced.Aer that, the compound 84 underwent Curtius rearrangement and was treated with phenols to produce carbamate 85.Aer that, polyphosphoric acid facilitated cyclization, which was then followed by pseudohalogenation to produce triate 86.Finally, the nucleophilic substitution of the piperazine 87 with triate 86 led to the desired Quetiapine 88 product (Scheme 13).
Based on the above-mentioned mechanistic investigations a proposed mechanism is illustrated in Fig. 3

Palladium catalyzed reactions
Indatraline is a potential psychoactive complex with signicant binding as well as inhibitory activity aimed at monoamine reuptake neuronal sites, together with serotonin transporters & dopamine. 84,85Behavioral assays and in vivo, dialysis have suggested that indatraline has a strong dopaminergic mode of action with a prolonged half-life. 86,87Additionally, indatraline was found to decrease the self-administration of cocaine in monkey trials. 88astre & Correia developed a synthesis of the psychoactive drug indatraline.To get a saturated b,b-di arylated product 91 with 85% yield, methyl cinnamate 89 was treated to Heck arylation with 3,4-dichloro benzene-diazonium tetra-uoroborate 90, as it was accompanied through an in situ catalytic hydrogenation of adduct 91.Due to the generation of side products during the dehalogenation process, control of a hydrogenation phase is important.Next, the ester 91 was hydrolysed through aqueous KOH to produce the analogous acid 92 in a 91% yield.Successive cyclization via PPA and/or ClSO 3 H produced the wellknown intermediate 93 of (±)-indatraline 94 in yields of 38% & 70% (Scheme 14). 89,90-Oxazolidinones have attracted considerable attention owing to their signicant heterocyclic scaffolds having a diverse range of pharmacological activities.Oxazolidinones are a signicant class, naturally existing substances and promising medicinal frameworks with a variety of biological and pharmacological activities, including antimicrobial, antibacterial, antidepressant, anti-Parkinson's, anticancer, and anti-HIV activity. 91,92The usage of 2-oxazolidinones as chemical precursors in organic synthesis is also very common.Consequently, the synthesis of such therapeutic heterocyclic compounds has received a lot of attention.
Arshadi et al. synthesized toloxatone with the brand name Humoryl, 33 is an antidepressant drug that is marketed in several different countries comprising 2-oxazolidinones moieties as a structural unit.It functions as a reversible selective MAO-A (RIMA) inhibitor. 93These valuable heterocyclic composites are also widely used in the construction of organic compounds. 94alladium-catalyzed carboxylation of secondary a,a-disubstituted N-propargyl amines 95 with CO 2 produced the highly substituted 2-oxazolidinones 96.Pd(OAc) 2 , nest effective for the conversion, including Pd 2 (dba) 3 , Pd(PPh 3 ) 4 , NiBr 2 (PPh 3 ) 2 , IrCl(CO) (PPh 3 ) 2 and RuH 4 (PPh 3 ) 2 .Substituted oxazolidinones 96 were then converted to toloxatone 97 over subsequent steps (Scheme 15). 95mong the most effective tricyclic antidepressants for blocking serotonin and norepinephrine reuptake is clomipramine.Although it raises the risk of seizures at high dosages, it has been proven to be useful in curing obsessive-compulsive disorder.
7][98] Casnati et al. reported the formal synthesis of clomipramine used commercially accessible 4-bromochlorobenzene 98, 2-bromoaniline 100, also norbornadiene 99, along with cesium carbonate and dimethyl formamide, to produce the anticipated 3-chloro-5H-dibenzo[b,f]azepine 101 in yield of 65%.This compound was easily transformed to the resultant dihydro compound 102 in 95% yield by a simple reduction of a conjugated (])-bond using the multipurpose Mg in MeOH at 50 °C for 1.5 hours.][101] Lumateperone, also known as ITI-007, is a strong 5-HT2A antagonist, post-synaptic D2 antagonist, and inhibitor of serotonin transport that was formed via Intra-Cellular Therapies. 102n 2017, the US FDA gave global approval for the single-dose oral administration of schizophrenia treatment in adults.The 5-HT2A, D2, D1/GluN2B, and SERT receptors exhibit a signicant selectivity for the tetracyclic quinoxaline-type substance. 103lick et al. described a simple and scalable pathway to lumateperone 119 and its structurally related compounds. 104ricyclic indole 107 was produced using a Fischer indole with ketone 106 starting with hydrazine 105. 105Reduction with tri-  A new class of antipsychotic medication called aripiprazole (Abilify) is primarily utilized to cure schizophrenia and bipolar disorder. 110Because of the generation of difficult-to-remove isomers 111 and the need for much more explosive Na azide as a nitrogen source and erosive TFA as the solvent, its conventional synthetic procedures usually gave poor yields.Yang et al. developed a faster synthetic pathway and milder reaction conditions allowed for a 77% total yield of aripiprazole using 120 as the initial substrate & current technology as the primary catalytic procedure.When the reaction was carried out in a Pd(TFA) 2 /BINAP/TsOH/H 2 O system, the NO 2 group was completely deoxygenated and carbonylated to generate the isocyanate, which was then internally hydro-cyclized to produce aripiprazole 125 (Scheme 18). 110[114][115][116][117][118][119] Ishizuka et al. reported an asymmetric production of milnacipran, initially, compound 129 was generated from radially available but2-yne-1,4-diol 126.By reacting with phenylboronic acid, compound 126 was transformed into (Z)-2-phenyl but-2ene-1,4-diol 127.Using monoacetylation catalyzed by porcine pancreas lipase (PPL), the C4-hydroxy groups of 127 were regioselectively preserved to provide 128.The C1-hydroxy group of 128 was protected with a t-butyldimethylsilyl group, and the C4-acetoxy group was then alkaline hydrolyzed to generate 129, which were then reacted with diiodomethane along with diethylzinc in 10 mol% of 130 to generate 131 with a yield of 87% (59% ee).Further primary hydroxy group of 131 was transformed into an azide; a t-butyldimethylsilyl group was then removed utilizing uoride ions, and eventually, primary alcohol was oxidized utilizing Jones reagent to produce carboxylic acid 132.The carboxy group of 132 was transformed to amide 133, the azide group of 133 was hydrogenated, and the reaction with HCl provided the required optically active (−)-milnacipran hydrochloride 134 with 72% enantiomeric excess (Scheme 19).The absorption of norepinephrine and serotonin is potently and specically inhibited by the drug nafenodone.Rao et al. described the effective synthesis of an antidepressant (S)-nafenodone.It was made possible by sterically hindered enantioselective a-arylation via palladium driven by chiral monophosphorus ligand BI-DIME L 13 .Pd-(S)-BI-DIME serving as a catalyst, tetralone 135 reacted with PhBr to produce 136 in an 80% efficient and 75% yield.(S)-nafenodone 137 was produced via ozonolysis, reductive amination, and subsequent reaction with HNMe 2 /Na(OAc) 3 BH (Scheme 20). 121he universal a,b-esters were well-known as important olen frameworks, and they were successfully used for parallel drug formation of (Z)-zimelidine.Ashida et al. reported the synthesis of an extremely selective serotonin reuptake inhibitor zimelidine, from readily available (Z)-stereo dened enol tosylates obtained from b-ketoesters 138 as well as a-formyl esters. 122arallel and stereo-complementary enol tosylations were achieved via treating with starting material, undergoing Suzukicouplings utilizing (3-Py)B(OH) 2 which gave the compound 140.
Our desired therapeutic molecule, (Z)-zimelidines 141, was then produced aer being further treated with DIBAL-H, SOCl 2 , and aq.dimethyl amine (Scheme 21). 1235][126][127] Triazole serves as the primary structural motif in a wide range of medicinal molecules, revealed to possess a variety of biological activities. 128,129n the FST and TST, the novel compound shows higher antidepressant efficacy than uoxetine, as well as modest anticonvulsant action.These compounds could be employed as supplements to existing antidepressants to cure depression in epilepsy patients.
Deng et al. described the synthesis of triazole-containing quinolinones.The readily accessible 3, 4-dihydro-2(1H)-quinolinone 142 underwent successive nitration and catalytic hydrogenation to synthesize the compound 144.Then, compound 144 was reacted with dimethoxy-N,N-dimethylmethanamine (DMF-DMA) as well as formyl-hydrazine in acetonitrile to produce compound 145.In contrast to uoxetine, the target compound 146 was produced by the successive alkylation 145 with a range of diverse alkylating agents (Scheme 22). 130ong et al. described the synthesis of triazole containing quinolinones as a potent antidepressant.Starting with nitroaniline 147 and treating it with propionic anhydride & acetic anhydride in reuxed acetic acid to produce the compound 148.NO 2 reducing conditions of Pd/C as well as hydrazine hydrates were used to reduce compound 148 to produce compound 149.Aer that, compound 149 was treated with formyl hydrazine and triethyl orthoformate in acetonitrile to produce compound 150.Finally, compound 151, which was produced by alkylating compound 150 with a range of diverse alkylating agents, demonstrated greater antidepressant ability than uoxetine in the TST and FST studies (Scheme 23). 131linical research on psychiatric disorders and migraines has concentrated on NK1 receptor antagonists. 132SSRIs are currently employed to cure mental illnesses because they prevent the uptake of 5-HT, which increases levels of 5-HT inside synaptic cle. 133,134][137] Risatti et al. reported the optimal a-arylation process which involves the formation of lithium enolate 153 using lithium dicyclohexyl amide accompanied via palladium with 154 utilizing tri-tert-butyl phosphonium tetra-uoroborate as a ligand to provide ester 155, That was then reduced using lithium aluminum hydride to generate alcohol 156 in yields of 77%.LAH was also used to convert N-Boc to N-methyl, with a yield of 78-82%.
Through an iron-catalyzed coupling and TCCA chlorination, the 2,4,6-trisubstituted pyridine is synthesized selectively.However, aer being treated with trichlorocyanuric acid 160, pyridine 159 was transformed into the necessary benzylchloride 161.Following the reaction, benzyl chloride 161 was produced as its p-toluene sulfonic acid (p-TSA) salt, including a dichloro impurity (5% LCAP) and leover starting molecule 159.Finally, salt of p-toluenesulfonic acid 161 was synthesized from 158 with a yield of 68%, requiring just two synthetic transformations as opposed to the Boekelheide method's four stages, which resulted in a yield of 54%.Additionally, the method for coupling completely functionalized pyridine and piperidine components was extremely convergent, evaded the processing of non-crystalline products, and needed no chromatographic purications.The crystalline HCl salt of 163, that were separated in 61-65% yield, was produced by etherifying the potassium alkoxide of 157 with a free base 162 (Scheme 24). 138

Gold-catalyzed reactions
Vessally et al. reported a metal-catalyzed intra-molecular cyclization of N-Boc-protected propargyl amines using the AuPPh 3 -Cl/AgSbF 6 combination as the catalytic system to produce functionalized 2-oxazolidinones. 139Other catalysts, such as Pt(CH 3 CN) 2 (SbF 6 ) 2 and AuCl 3 , were discovered to increase the reaction in the optimization study, however, Au(PPh 3 )SbF 6 provided the best results.N-Boc-protected propargyl amines 164 produced alkylidene 2-oxazolidinones 165 with fair to high yields and exceptional (Z)-selectivity under optimal conditions.Other merits of this synthetic methodology included simplicity, low reaction times, and a wide range of substrate scope.For instance, in the production of the antidepressant toloxatone 97 (Scheme 25). 140

Manganese-catalyzed reactions
Desipramine is employed to treat depression, that works by enhancing the activity of a chemical called norepinephrine in the brain.This medication is a tricyclic anti-depressant.It might also be suitable to cure indications of attention-decit hyperactivity disorder (ADHD). 141as et al. synthesized the precursor molecule 168 with exclusive anti-Markovnikov selectivity produced by hydrogenating allyl alcohol 166 with N-methylated aniline 167 and was transformed to chloro derivative 169 in yield of 87%, which was catalyzed via phosphine free Mn(I) L 11 complex found abundantly in Earth and was carried out under hydrogen-borrowing conditions.Then, imino-dibenzyl treatment and debenzylation produced the antidepressant medication desipramine 172 in two steps with combined yields of 61% (Scheme 26). 142-Amino alcohols serve as efficient synthetic intermediates for a variety of drugs and bioactive compounds.143 Das et al. reported the synthesis of uoxetine using a phosphine-free Earth's abundant Mn(I) catalyst.Under hydrogen-borrowing conditions, Mn(I) composite catalyzed the selective hydroamination of allyl alcohols & 2°allylic alcohols with exceptional functional compatibility.3-Benzyl(methyl)amino phenyl propane-1-ol 175, produced by treating 1-phenylprop-2-en-1-ol 173 with N-methyl-1-phenylmethanamine 174 and subjecting it to Mn, is then hydrogenated by using Pd/C in methanol at 60 °C for 16 hours.When the amine 176 was treated with 4-chlor-obenzotriuoride 177, it produced 178, as the hydrochloride salt (Scheme 27). 142Vortioxetine is a member of the bis-aryl-sulfanyl amines class and is chemically known as 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]-piperazine.Its main effects are the direct modulation of the 5-HT receptor and the selective blockade of SR (by inhibiting the SERT).144 Mao et al. reported the synthesis of vortioxetine hydrobromide on a hectogram scale.Starting with 2,4-dimethylbenzenethiol 180 and 1-chloro-2-nitrobenzene 179, both of which are readily available in the market, the reaction with potassium carbonate in acetonitrile produced the desired intermediate 181 that was then puried through recrystallization in acetonitrile to yield the pure product in a total yield of 89%.145 The required the aniline derivative 182 is produced in 74% yield when the generated nitrophenylsulfane derivative 181 undergoes catalytic hydrogenation in the presence of Mn-1 under the optimal reaction conditions.It is worth noting that the activity of transition metals is frequently impeded by thioand amino groups.Additionally, several Mn(0) species produced in late transition-metal catalyzation processes experience (C-S) oxidative additions which can be avoided by using Mn-L 13 .The required vortioxetine 184 is then produced by the reaction of 182 with 2-chloro-N-(2-chloro-ethyl)ethane amine hydrochloride 183 (Scheme 28).146,147

Copper-catalysed reactions
In many biological molecules, 1,5-benzo thiazepines are preferred heterocyclic pharmacophores. 148Ogawa et al. described speedy accessibility to 1,5-benzothiazepines using mesityl copper/(R)-DTBM segphos (DTBM = 3,5-di-tert-butyl-4 methoxy), pre-catalyst for conjugate addition of a,b-unsaturated thioamides 185 & thiophenol 186.The complex of mesitylcopper and (R)-DTBM segphos L 1 may function as effective catalysts for direct enantio-selective production of C-S bonds.Several 1,4-conjugate addition compounds were produced by successfully using a range of electron-rich and decient a,bunsaturated thio-amides as electrophilic substrates in toluene at 0 °C.The second conversion required the utilization of methyl iodide for methylation of thio-amide functionalities, which produced a transitory thioester that was cyclized at 80 °C using a catalytic proportion of p-toluene sulfonic acid monohydrate (TsOHH 2 O).Following side chain addition, a 93% yield of (R)-thiazesim 190 was achieved (Scheme 29). 149eboxetine, a selective norepinephrine reuptake inhibitor1 (SNRI), is used to treat depression, narcolepsy, cocaine dependence disorder, and hyperactivity disorder. 150,151In contrast to its (R,R) enantiomer, (S,S)-reboxetine is much more potent and specic for both nor-epinephrine transporters. 152iu et al. used Cu-L 6 chiral amino alcohol-copper(II) catalyst to facilitate the diastereoselective nitro-aldol reactions of nitromethane with chiral aldehyde, which potentially leads to the privileged synthesis of specic stereoisomer for nitro-diol derivatives, Cu-L 15 chiral amino alcohol-copper(II) catalyst was used.The nitro-aldol adduct (1S,2S) 192 was produced in 86% yield when the aldehyde (1S,2S) 191 was reacted with CH 3 NO 2 in the presence of Cu-L 6 .The O-TBS-protected molecule 192 was rst deprotected with 3 N HCl to generate the diol 193, which was then hydrogenated with Pd/C and subjected to a series of treatments with ClCH 2 COCl while being accompanied by a base to yield the chloroacetamide derivative 194 in 71% yield.The morpholine derivative (2S,3S) 195 was developed in 70% by cyclizing the amide derivative (2S,3S) 194 with t-BuOK, then reducing the amide with LAH and protecting it with N-Boc.Ultimately, derivative 195 was converted to (S,S) reboxetine 26 in 85% yield (Scheme 30). 153uloxetine, a powerful antidepressant for the treatment of serious depressive disorders. 59Inhibitors of serotonin and norepinephrine reuptake for the treatment of several illnesses associated with depression. 154,155Larik et al. reported that thioamides are employed as signicant precursors for (C-C), leading to an aldol product having 92% ee for the enantioselective direct asymmetric aldol reaction that produces (S)duloxetine.The chirality has been produced by constructing a so Lewis acid/hard Brønsted base co-ordinated catalyst consisting of [Cu(CH 3 CN) 4 ]PF 6 , (S,S)-PhBPE L 16 , and Li(OC 6 H 4 -p-OMe), where thioamide was chemoselectively activated via so-so interaction of Cu + and sulfur atom, resulting in the unique production of the thioamide enolate in aldehyde which undergoes reduction and synthesized compound 199.Molecule 200 was produced in two steps using 5 mol% of Pd(PPh 3 ) 4 and N,N-dimethyl of barbiturates in DCM at 50 °C.This molecule then underwent LiAlH 4 reduction to produce molecule 201.The nal target product 37 was then produced with a 65% yield by adding sodium hydride and 1-uoro naphthalene (Scheme 31). 156ang et al. reported the synthesis of triple reuptake inhibitor (TRI) ALB 109780, which prevents the reuptake of serotonin, norepinephrine, and dopamine, may help cure depression. 157n the proximity of potassium carbonates, copper(I) iodide as well as L-proline in DMS (dimethyl sulfoxide), the reaction between compounds 202 and 203 produced the intended product 204 as the light-yellow limpid solid in 68% yield.A preliminary analysis of the reaction situations for the a-arylation of 204 showed that BINAP, NaOt-Bu, and Pd(OAc) 2 were the best catalysts for this reaction.Compared to toluene, dioxane oen offered superior adaptation and crude purity.Regardless of the quantity of catalyst utilized, increasing the addition of compound 205 harms the reaction's crude purity.Higher base concentrations resulted in improved conversion.With 1.2 equiv. of compound 205 at 80 °C, 5% Pd(OAc) 2 , BINAP as the ligand in dioxane, and 1.5 equiv. of NaOt-Bu, the best results were obtained.
Borane-dimethylsulde (BMS) was used to reduce 206 in the presence of THF and 6 N HCl at 35 °C in a nitrogen environment.The resultant solution was then stirred at 40 °C till it was nished.Over the reduction and treatment with charcoal, compound 207 was separated also as a yellow solid with a 66% yield.Aer the treatment, purity rose to 95.4% from 87.5%.
By adding (+)-DTTA to a racemic 207 solution in acetone at reux, 207 was resolved using (+)-di-p-toluoyl-D-tartaric acid.The resultant solution was chilled to 5 °C to yield the required product as the white solid via ltration in 81 to 88% ee.Aer the isolated product was recrystallized using heptane as an antisolvent to speed up crystallization and 10% THF/EtOH at reux (68 °C), the chiral limpidness was signicantly improved to 98.8% enantiomeric excess.On a scale, 208 was reacted with 6 equiv. of Na 2 CO 3 solution while being immersed in a mixture of aq.acetone.The resulting suspension underwent ltration to provide 97.1% HPLC purity and a quantitative yield of the target product.It was discovered that the chiral purity was 94.3%.The free base 209 was allowed to react with a solution of 1.1 equivalent to maleic acid aer being heated to reux in ethanol.It was ltered aer cooling to 5 °C, yielding the anticipated product 210 as a white solid with a yield of 91% and HPLC purity of 98.1%.Aer isolation, the chiral purity was found to be greater than 99.9%.Additionally, small-scale investigations showed that during salt generation, from the starting substrate with only 86% ee, the chiral purity is sometimes increased to 99% (Scheme 32). 157wamori & Nakada synthesized Hyperforin, which was derived from Hypericum perforatum L., which prevents synapses from reabsorbing neurotransmitters. 158,159The compound known as hyperforin, which belongs to the family of polyprenylated acyl phloroglucinols (PPAPs), is composed of a strongly oxygenated and highly substituted bi-cyclo[3.nonane or bicyclo[3.2.1]octane motif using geranyl or prenyl side chain derivatives prepared by intramolecular cyclopropanation. 160,161ntra-molecular cyclopropanation (IMCP) of 211, produced from methyl 2,6-dimethoxy benzoate by a series of steps, was accompanied by stereo-selective alkylation of the cyclopropane 212 via copper catalyzed complexes with 2,2 0 -(propane-2,2-diyl) bis(4,5-dihydro oxazole), and region-selective ring opening of a cyclo propane moiety to afford 213.Compound 213 was transformed to compound 217 through chemo-selective as well as stereo-selective hydroboration of 213 using disiamyl borane for further protection of the subsequent hydroxyl as TIPS ether generated 214.Synthesis of an enol triate of 214 using Comins' reagent and Pd carbonylation provided 215.By hydrogenating the C6-C7 alkene in 215 using Crabtree's catalyst, chemo-and stereo-selective reduction of the C6-C7 alkene were accomplished, leading to the only product 216 aer reuxing dichloroethane.The directing effect of a C2-C3 methoxy alkene may be responsible for this stereoselectivity.Preferential acetylation of a 1°hydroxyl and then Dess-Martin oxidation of a C-9 secondary hydroxyl produced product 217 from the reduction of 216 with DIBAL-H.Palladium-catalyzed oxidation of 217 was used to achieve allylic oxidation, yielding 218, which was then modied by Dess-Martin oxidation, Wittig reaction, and elimination of the TBS group to yield 219.As mentioned earlier, Wittig reactions were also used to synthesize the allyl group at the C-7 position.In other words, potassium carbonate in methanol removed the acetyl groups from 219, which were then proceeded via DMP and Wittig process to give 220.Aer compound 220 underwent acid hydrolysis, compound 221 with an allyl group at the C-7 position was successfully produced by the Wittig reaction.Lithium 2,2,6,6-tetra-methylpiperidide was necessary for allylation at the C-5 position of 221, as LDA reduced the C9 ketone.Under the same circumstances, subsequent allylation at a C-3 site did not occur, requiring the utilization of thienyl cuprate as an additive, thus giving compound 222.Compound 222 was exposed to a reaction with TBAF to construct the C-1 isopropyl ketone, and a Dess-Martin oxidation process followed to produce aldehyde 223.
The required product was successfully obtained with a trace amount of the reduced product from the treatment of molecule 223 with the isopropyl cerium, which was successfully prepared in situ from CeCl 3 $2LiCl and isopropyl magnesium chloride.Cross metathesis was subjected to 224, which was produced by the subsequent Dess-Martin oxidation.In the Grubbs II reagent at 60 °C, the reaction of 224 with isobutene produced a variety of products, some of which comprised compounds with cycloheptene rings that were obtained from the ring-closing metathesis among the C-7 and C-8 substituents.

Rhodium-catalysed reactions
A lot of attention has been attracted to the asymmetric synthesis of optically active 1,5-benzo thiazepines that have chiral drugs in the form of a sulfur-substituted stereocenter.Yin et al. successfully developed asymmetric hydrogenation of the number of conjugate C]C, using the Rh/ZhaoPhos catalytic system, which consists of the chiral ferrocene-based bis-phosphine & thiourea moiety as ligand.With an efficient S/C ratio of 100, asymmetric hydrogenation of 226 produced the compound (R)2-phenyl-2,3dihydro benzo[b] [1,4]thiazepin 4(5H)-one 227 having the yield of 98% (98% ee).The antidepressant drug (R)-(−)-thiazesim 190 could be easily converted from the hydrogenation product 227 with outstanding efficiency (Scheme 34). 163enlafaxine, a member of the phenylethylamine class of antidepressants with a unique structure, has a chiral center at a benzylic position, a tertiary amine & a tertiary hydroxy group. 164,165reskorn described The C-H insertion reactions of bissilylmethylamine 230 using different aryl diazo-acetates 229 were catalyzed via dirhodium-(II)-prolinate, Rh 2 (S-DOSP) 4 L 20 and produced b-amino esters in 62% yield and 93% ee.It was observed that HCHO/NaBH(OAc) 3 was a viable substitute since it effectively converted 231 to 232 in a yield of 82% at room temperature without losing ee.Finally, (S)-venlafaxine 234 was synthesized by reacting 232 with pentyl-1,5 magnesium bromide 233.The Grignard reagent and the ester solutions have to be added slowly and simultaneously to the reaction vessel to achieve the best results.Aer working up the reaction, producing the HCl salt, and enriching by recrystallization, (S)-234 was produced in a yield of 49% and 99% ee (Scheme 35). 1668][169][170][171][172] Huang et al. described for the rst time addition of aryl-boroxines to modest aryl ketones in a highly enantioselective manner, using a Rh/(R,R,R,R)-WingPhos to produce chiral diaryl alkyl carbinols.It has been established that Rh/(R,R,R,R)-WingPhos is important for the signicant reactivity and enantio-selectivity.Because of the two anthryl units in its composition, (R,R,R,R)-WingPhos can not only provide the necessary stereo-control but also help to bring two reactions together and increase reactivity. 173he targeted tertiary alcohol 236 was effectively produced in 70% yield (99% ee) by adding 4-uoro-phenyl boroxine to 4chloro-1-(2,4-dichloro phenyl)butan-1-one 235 using the Rh/ (R,R,R,R)-WingPhos L 21 , which has excellent functional group compatibility.The lactone 237 was produced with a 73% overall yield by SN 2 displacement of chloride in 236 with amines and then cyanation-lactonization under palladium catalysis.Escitalopram 238 was produced with a combined yield of 61% and enantiomeric excess of more than 98% aer being reduced from 237 using DIBAL-H/NaBH 4 and then having the ring closed with MsCl treatment.Thus, using this methodology, a fresh, brief, and extremely enantioselective synthesis of escitalopram was established (Scheme 36).
Scheme 34 Synthesis of thiazesim.A simplied mechanism for this rhodium-catalyzed asymmetric inclusion of arylboroxines to simple aryl ketones is proposed in Fig. 4. Transmetallation of the aryl boron with the [Rh(Cl){(R,R,R,R)-WingPhos}] species provides the aryl-Rh species A. This step is followed by the coordination of an aryl ketone to form the species B. The favorable conformer undergoes insertion and transmetallation with another aryl boron reagent to provide the chiral tertiary alcohol product with the ascertained stereochemistry and regenerates A (Fig. 4). 173avies et al. reported that cyclohexadienes can be successfully subjected intermolecularly to C-H insertion of phenyl diazoacetates via dirhodium tetrakis((S)-N-(dodecyl benzenesulfonyl)prolinate) (Rh 2 (S-DOSP) 4 ) L 22 , resulting in the asymmetric production of diarylacetates.The 1,4-cyclohexadiene 240 was produced in 99% ee by the vinyl di-azoacetate 239 and 1,3cyclohexadiene which was catalyzed via Rh 2 (S-DOSP) 4 L 22 .The use of cyclohexadiene 241 as a precursor for the formal synthesis of (+)-sertraline 34 has many advantages.The 4,4diaryl butanoate 242 was produced by oxidizing 241 with DDQ and catalytic hydrogenation, with only minimal racemization (96% ee).The tetralone 243 was produced by ester hydrolysis of 242 via an intra-molecular Friedel-Cras acylation (79% yield for two processes), which was then transformed into (+)-sertraline 34 (Scheme 37). 174ulton et al. reported a potent method to construct stereogenic centers is the asymmetric hydrogenation of the olen functional group using rhodium di-phosphine catalysts and an (S)-PhanePhos ligand L 23 . 175Z/E-olen isomers produce different enantiomers in a given catalytic system, the compound 244 (19 : 1 E/Z mixture of olens) needed to be employed as (almost) a single isomer to obtain excellent enantio-selectivity.The racemic form of 4,4-diaryl-3-butenoate 245 was produced by hydrogenating the tert-butylammonium salt 244 using a 1 : 1 E/Z mixture of olens.The hydrogenated product was cyclized by rst treating it with 2 M H 2 SO 4 to release a free acid, and then with chloro-sulfonic acid to produce tetralone 246 91% of the time.Tetralone 246 was then employed to develop sertraline 34 by reductive amination with methylamine (Scheme 38). 176s a result of selective inhibition of the absorption of human synaptosomal serotonin, (+)-sertraline (Zolo) has become the medication that is most usually used for the treatment of depression. 177,178It is frequently employed for treating depression, as well as occasionally OCD, PTSD, and panic attacks.
Wang et al. described the production of chiral gem-diaryl alkanes in signicant yield and enantiomeric excess was enabled by chiral sulnylphosphine ligands, which successfully promoted Rh-catalyzed arylation to chalcones.In aqueous KOH in dichloromethane (DCM), phenylboronic acid 248 has been introduced to the b,g-unsaturated a-ketoamides & ligand L 24 .Rh(C 2 H 4 ) 2 Cl 2 served as the catalyst.Amide 247 yields the 1,4adduct 249 over 86% while exhibiting outstanding 1,4-selectivity.Without losing the enantiomeric excess, the 1,4-adduct 249 (98% ee) was transformed into 1,3-dithiolane 250 and subsequently reduced to produce g,g-diarylamide 251.Using concentrated HCl heated under reux for about 20 hours, the amides 251 were then hydrolyzed to generate 252.The tetralone 253 was then produced by subjecting product 252 to an acidcatalyzed cyclization 179 which resulted in a 60% yield and a 92% enantiomeric excess.Tetralone 253 is used as a preliminary step in the production of sertraline 34 (Scheme 39). 180hang et al. described using the asymmetric hydrogenation of g-branched N-phthaloyl allyl amines with bis-phosphine-Rh complex and (R)-SKP, [Rh((R)-SKP)(cod)]SbF 6 bearing a high biting angle, it is possible to produce enantioselective glochlorogenic amine derivatives with outstanding enantioselectivity (up to >99% ee) and decent yields.The intended product 255 could also be produced by hydrogenating 254 in EtOAc with L 25 (S)-SKP/[Rh(cod) 2 ]SbF 6 at 50 000 S/C at room temperature and 50 atm H 2 .This method produced the intended product 255 in a good yield and with great enantioselectivity.The antidepressant medication Fluoxetine 178 was produced in various steps with >99% ee by varying the N-substituent from phthaloyl to methyl.This process yielded 83% of the desired product from the starting material 254 (Scheme 40). 181

Iridium-catalysed reactions
3][184][185] Liu et al. reported for (AH) of various g-amino ketones.An effective catalytic system utilizing iridium and chiral tri-dentate ferrocene-based phosphine bearing unsymmetrical vicinal diamines were developed.Ir-(RC,SP,RC)-L 26 catalyst efficiently hydrogenated 259, maintaining good results 97% yield and 99% ee.The respective amino alcohols result in the complete production of the desired compounds.It suggested that there was a great deal of potential for this Ir-catalyzed asymmetric conversion in industrialized applications.Additionally, N-Boc-N-methyl-(3-hydroxy)-3-(2-thienyl)propanamine 260 was obtained by Boc-protection of R-7, accompanied by Mitsunobu coupling to produce Boc-protected duloxetine 261, which was then deprotected to yield duloxetine 37 (Scheme 41). 186,18790][191] The neuronal uptakes of norepinephrine (NE), serotonin, or dopamine are all inhibited to an equivalent extent by the triple monoamine reuptake inhibitor diclofensine.It is a molecular derivative of tetrahydroisoquinoline (THIQ). 192,193The a,a-diaryl acetamide 270 was produced in 75% yield & 92% ee by stereospecic coupling of 268 and 269.[197] 10 Cobalt-catalysed reactions Paroxetine, a powerful inhibitor of serotonin reuptake, is frequently recommended to cure depression, social anxiety, post-traumatic stress, OCD, and panic disorder. 198,199espiau et al. reported cobalt-catalyzed cross-coupling reaction used to build the scaffold of the 3,4-disubstituted piperidine in a rapid way to produce (±)-paroxetine.Tri-ethyl amine (2.1 equiv.) was used as the base for the process of regioselective tosylation of diol 273, which resulted in a high yield and the generation of bromide 276.When the sesamol group was introduced with Cs 2 CO 3 in DMF, adduct 275 was produced in 51% yield.By utilizing tetra-butyl ammonium hydroxide as a phase transfer catalyst and exposing a toluene solution of 274 and sesamol to aqueous NaOH, this yield increased to 76%.Finally, Bromo tri-phenyl phosphonium bromide was used to convert alcohol 275 into bromide 276 with a 65% yield.
Cross-coupling of 4-uorophenyl magnesium bromide with bromides 276 using Co(III) acetyl-acetonate (acac) along with TMEDA and hexamethylenetetramine (HMTA) revealed cis-276 producing a 16% yield of coupling product 277 with enhanced selectivity for trans-277.Aer removing the Boc protecting group and undergoing recrystallization from 2-propanol, the synthesis of (±)-paroxetine 266 was nished (Scheme 44). 200,2013][204][205] Lu et al. reported that this methodology has been utilized as the crucial step in the formation of the vilazodone derivative 282 from a readily accessible precursor 278.When the intermediate 280 was C-H arylated, the corresponding product 281 was produced in a 76% isolated yield and was easily transformed into a 2-arylated vilazodone derivative 282 (Scheme 45). 206,207ntidepressants, neuroleptics, and antiarrhythmics are only a few of the therapeutic classes represented by cationic amphiphilic drugs (CADs).Cationic amphiphilic drugs can enter cells and their organelles in their neutral, lipophilic form.These medications are effectively protonated and consequently conned in acidic cellular compartments, such as lysosomes.By making drugs more permeable to BBB in the brain, the antidepressant effect is enhanced.
Hariprasath et al. reported by treating amines 298 with aromatic aldehydes 299 such as para diethyl and dimethyl amino benzaldehyde, Schiff's base of sulphadiazine was formed.By reacting with MeI, the synthesized Schiff's bases 300 were changed into their cationic amphiphilic bases 301.These bases were treated with metals such as ZnCl 2, CdCl 2 , and CuCl 2 , to produce metal complexes 302.Both zinc and copper metal complexes demonstrated remarkable anti-inammatory and antidepressant properties (Scheme 46). 208,209ilazodone, an SSRI as well as a partial agonist of the serotonin 5-HT1A receptor, is utilized to cure major depressive disorder (MDD).5). 212,213gomelatine is a melatonin bio-isosteric derivative in which the naphthalene core has taken the place of the indole core. 214,215As a 5-HT2C receptor antagonist and agonist of MT1/ MT2 melatonergic receptors, agomelatine can resynchronize disrupted circadian rhythms, alleviating sleep disorders. 216tathakis et al. described that by combining vinylic organometallics with 7-methoxy-1-tetralone 310 the main building block for the synthesis of agomelatine carbinol 312 was obtained.In the next step, intermediate 313 could be obtained from carbinol 312 through allylic substitution, which is the crucial step, utilizing chlorination agents such as PCl 3, SOCl 2, or HCl as well as isomerization of the double bond.Next, chloride 313 had to be oxidized to produce the equivalent aromatic derivative 314; this was primarily done by consuming Pd in the manifestation of a hydrogen acceptor.The desired ammonium chloride 315 is produced in a decent yield by heating molecule 314 in equal volumes of EtOH and aq.NH 3 at 100-105 °C in an auto-clave for 6 hours.By employing AcONa and Ac 2 O in EtOH heated to reux, the acetylation of ammonium salt 315 to the analogous acetamide 316 completed the nal API synthesis.Aer a simple re-crystallization, the pure molecule 317 was obtained with a purity of more than 99.5% (Scheme 48). 217,218

Conclusion
Metal-catalyzed reactions have played a signicant impact in the development of new pharmaceuticals, particularly  antidepressants, and have transformed the eld of organic synthesis.The development of more sustainable and effective routes for the synthesis of antidepressant compounds has been achieved via metal-catalysts.These reactions can provide the pharmaceutical industry with signicant advantages, including benign reaction conditions, increased efficiency, and minimal waste output.It is estimated that metal-catalyzed reactions play a main role in the synthesis of antidepressant molecules and other therapeutics in the future owing to the ongoing advancement of novel catalysts and the continual improvement of synthetic methodologies.

Future perspectives
Developments in the eld of chemistry, particularly in drug discovery and synthesis, occur rapidly.The future outlook for metal-catalyzed reactions in antidepressant molecule synthesis is promising.Researchers are likely to continue exploring new methodologies, enhancing existing processes, and addressing challenges related to scalability and regulatory requirements.Through that comprehensive survey, synthetic chemists and pharmacists develop new ideas for the derivatization of these molecules.Depressant-related diseases led to the outcome of severe mortalities in the world especially in developing countries due to various factors.So, there is a desperate need to summarize the overall possible synthetic routes through the utilization of different metals and their complexes for the synthesis of antidepressants.

Fig. 1 Scheme 1
Fig. 1 General mechanism of action of antidepressants.
ethylsilyl hydride, treating the resultant product with (R)-mandelic acid in MeOH, consequent synthesis of the (S)-mandelic acid diastereomeric salt, and free-basing with aq.NaOH yielded pure cis-indoline chirally 108.Protection of the amine and consequent Buchwald-Hartwig 106,107 with 111 gave cyclization precursor 112.Tetracycle 114 was produced by spontaneous ring closure as a result of the N-alkylation of ethyl bromoacetate 113, following hydrolysis of the diphenylamine.Piperazine 115 was produced by again N-alkylation, following carbonyl reduction with borane in THF.The fully elaborated cis-tetracycle 118 was synthesized via hydrolysis of carbamate and N-alkylation using 4-chloro-1-(4-uorophenyl)butane-1-one 117.Lumateperone tosylate 119 was produced by dissolving 118 in isopropanol and treating it with a p-toluene sulfonic acid solution (Scheme 17).108,109

Scheme 32
Scheme 32 Synthesis of ALB 109780, a triple reuptake inhibitor.

Fig. 4
Fig. 4 Mechanism for the synthesis of escitalopram.

Scheme 40
Scheme 40 Synthesis of fluoxetine.

Scheme 46
Scheme 46 Synthesis of cationic amphiphilic drugs.